Marker: D13Mgh6 |
| Symbol: |
D13Mgh6 |
| Previously known as: |
oxsts5530; R3172;
|
| RGD ID: |
34124 |
| Expected Size: |
108 (bp) |
| Position |
| Rat Assembly | Chr | Position (strand) | Source | JBrowse |
|---|
GRCr8 | 13 | 99,745,300 - 99,745,408 (+) | Marker Load Pipeline | | mRatBN7.2 | 13 | 97,213,755 - 97,213,863 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 13 | 103,613,626 - 103,613,733 | NCBI | Rnor6.0 | Rnor_5.0 | 13 | 108,279,035 - 108,279,142 | UniSTS | Rnor5.0 | RGSC_v3.4 | 13 | 101,704,193 - 101,704,301 | RGD | RGSC3.4 | RGSC_v3.4 | 13 | 101,704,194 - 101,704,301 | UniSTS | RGSC3.4 | Celera | 13 | 96,726,130 - 96,726,237 | UniSTS | | RGSC_v3.1 | 13 | 101,893,236 - 101,893,344 | RGD | | RH 3.4 Map | 13 | 656.7 | RGD | | RH 3.4 Map | 13 | 656.7 | UniSTS | | RH 2.0 Map | 13 | 716.2 | RGD | | Cytogenetic Map | 13 | | RGD | |
|
| Is Marker For: |
Strains:
ACI/N
AVN/Orl
BBDR/Rhw
BBDP/Rhw
BC/CpbU
BDIX/Han
BN/SsNHsd
BP/Cub
BUF/Pit
COP/OlaHsd
DA/PitN
FHH/Eur
F344/Pit
GH/Omr
GK/KyoSwe
DON/Melb
M520/N
IS/Kyo
WN/N
LH/Mav
LE/Mol
LEW/Pit
LOU/CHan
LN/Mav
MHS/Gib
MNR/N
MNRA/N
MNS/Gib
MR/Pit
NEDH/K
NP9
ODU/N
OKA/Wsl
OM/Ztm
P5C
PVG/Pit
SD/Rij
SHR/OlaHsd
SR/Jr
SHRSP/Riv
SS/Jr
WAG/RijKyo
WF/Pit
WKY/OlaHsd
WTC/Kyo
SHR.SS-(D13Rat1-D13Mgh6)/Mco
QTLs:
Gluco63
Pur32
|
QTLs in Region (GRCr8)
| 7207885 | Glom27 | Glomerulus QTL 27 | 3.9 | | kidney glomerulus integrity trait (VT:0010546) | kidney crescentic glomeruli count to kidney normal glomeruli count ratio (CMO:0002139) | 13 | 21120177 | 109350286 | Rat |
| 738027 | Lnnr6 | Liver neoplastic nodule remodeling QTL 6 | 3.3 | | liver integrity trait (VT:0010547) | liver remodeling tumorous lesion number (CMO:0001461) | 13 | 65613454 | 109350286 | Rat |
| 7387280 | Uae43 | Urinary albumin excretion QTL 43 | 5.69 | 0.4174 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 13 | 68983334 | 109350286 | Rat |
| 2293702 | Bss34 | Bone structure and strength QTL 34 | 4.61 | 0.0001 | femur strength trait (VT:0010010) | femur midshaft polar moment of inertia (CMO:0001669) | 13 | 67635937 | 109350286 | Rat |
| 1576318 | Schws5 | Schwannoma susceptibility QTL 5 | | 0.0351 | nervous system integrity trait (VT:0010566) | post-insult time to trigeminal nerve neurilemmoma formation (CMO:0002019) | 13 | 64497900 | 109350286 | Rat |
| 1354621 | Rf47 | Renal function QTL 47 | 3.7 | | kidney renin amount (VT:0010559) | kidney renin level (CMO:0002166) | 13 | 11081740 | 103588154 | Rat |
| 1354655 | Bp241 | Blood pressure QTL 241 | 3.9 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 13 | 38975045 | 103588154 | Rat |
| 8655951 | Rf63 | Renal function QTL 63 | 12.2 | | blood urea nitrogen amount (VT:0005265) | plasma urea nitrogen level (CMO:0000586) | 13 | 71610804 | 109350286 | Rat |
| 4889606 | Gluco63 | Glucose level QTL 63 | 2.86 | 0.003 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 13 | 83286150 | 109350286 | Rat |
| 8655959 | Pur32 | Proteinuria QTL 32 | 8.4 | | urine total protein amount (VT:0000032) | urine total protein excretion rate (CMO:0000756) | 13 | 72984506 | 99745408 | Rat |
| 2293687 | Bss26 | Bone structure and strength QTL 26 | 4.6 | 0.0001 | femur morphology trait (VT:0000559) | femur cross-sectional area (CMO:0001661) | 13 | 67635937 | 109350286 | Rat |
| 12879475 | Bp400 | Blood pressure QTL 400 | | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 13 | 64375743 | 109350286 | Rat |
| 1354666 | Bp244 | Blood pressure QTL 244 | 4.9 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 13 | 1 | 103588154 | Rat |
| 2293341 | Glom15 | Glomerulus QTL 15 | 9.1 | | kidney glomerulus integrity trait (VT:0010546) | kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) | 13 | 67635937 | 109350286 | Rat |